LG
Ligand Pharmaceuticals, Inc.
LGNXZ · OTC
$0.00 -55.56% (-$0.00)
1M -45.65%
Market Cap $90.2K
P/E Ratio 0.00x
Div. Yield -
ROE 20.06%
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/E 0.00x
EV/EBITDA 0.72x
P/S 0.00x
Growth
77 /100
Growing Rev. growth 17.72%
Book val. growth 8.00%
EPS growth N/A
Profitability
100 /100
Strong Gross margin 90.70%
Net margin 67.88%
Op. margin 34.45%
Quality
49 /100
Average ROIC 3.88%
ROE 20.06%
ROA 9.02%
Debt
82 /100
Low Debt/Equity 1.17x
Current ratio 30.49x
Int. coverage 22.22x
Stability
31 /100
Unstable Beta 0.98x
Rev. volatility 37.46%
EPS volatility 1,194.95%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre LGNXZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report